Kodai Capital Management LP Acadia Pharmaceuticals Inc Transaction History
Kodai Capital Management LP
- $2.53 Trillion
- Q1 2025
A detailed history of Kodai Capital Management LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Kodai Capital Management LP holds 53,497 shares of ACAD stock, worth $1.07 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
53,497Holding current value
$1.07 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
347Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$861 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$242 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$180 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$124 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.25B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...